Abstract
The principal cause of chicken T-lymphomas and their accompanying demyelinating disease is infection with Marek’s disease virus (MDV) (Calnek et al. 1997), a herpesvirus. Mareks disease can be prevented by vaccination with an antigenically related nonpathogenic herpesvirus, HVT (turkey herpesvirus). MDV is among the most potent oncogenic herpesviruses, and induces tumors as early as 4 weeks post-inoculation. As such, the virus is likely to encode a direct-acting oncogene or transforming gene. To search for a possible candidate(s), early studies focused on genes expressed in tumor cells or transformed cells. In general, in these cells where there is no virus production, the transcriptional activities are confined to the repeat regions only, which, based on BamHI digestion map, span the BamH, -I2, -Q2, -L, and -A fragments (Ross 1999). Within this region, most of the open reading frames are short and their existence as proteins not conclusively resolved. The exceptions are pp38, ICP4, and Meq, for which the protein products have been clearly identified.It should be noted that most of these studies were carried out using the entire population of tumor cells and cell lines; it is not clear whether all these proteins are expressed in the same or different cell populations. This is an important issue, as in any given latent state, there is usually a fraction of cells, spontaneously releasing viruses, which may contribute to the detection of some lytic gene products. In surveying through the literature, Meq, the focus of this chapter, emerges as one that is most consistently expressed in all tumors and transformed cell lines, both at the transcript and at the protein level. Meq has a structure resembling nuclear oncogenes and, as will be described in detail below, shared properties, characteristic of oncogenes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson AL, Kenney S (1999) The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 73(8):6551–6558
Askovic S, Baumann R (1997) Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA. J Virol 71(9):6547–6554
Baumann M, Mischak H, Dammeier S, Kolch W, Gires O, Pich D, Zeidler R, Delecluse HJ, Hammerschmidt W (1998) Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-Otetradecanoylphorbol-13-acetate-induced phosphorylation. J Virol 72(10):8105–8114
Baxevanis A, Vinson C (1993) Interactions of coiled coils in transcription factors: where is the specificity? Curr Opin Gen Dev 3:278–285
Brunovskis P, Qian Z, Li D, Lee LF, Kung HJ (1996) Functional analysis of the MDV basic leucine zipper product, Meq. The 5th International Symposium on Marek’s Disease. American Association of Avian Pathologists, Kellogg Center, Michigan State University, East Lansing, Michigan
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60(3):509–520
Calnek BW, Witter RL (1997) Marek’s disease. Iowa State University Press, Ames, Iowa, USA
Chesi M, Bergasagel PL, Shonokun O, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl WM (1998) Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91(19):4457–4463
Chi T, Lieberman P, Ellwood K, Carey M (1995) A general mechanism for transcriptional synergy by eukaryotic activators. Nature 377(6546):254–257
Delling U, Roy S, Sumner-Smith M, Barnett R, Reid L, Rosen CA, Sonenberg N (1991) The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA. Proc Natl Acad Sci USA 88(14):6234–6238
Elenbaas B, Dobbelstein M, Roth J, Shenk T, Levine AJ (1996) The MDM 2 oncoprotein binds specifically to RNA through its RING finger domain. Mol Med 2(4):439–451
Francis A, Ragoczy T, Gradoville L, Heston L, El-Guindy A, Endo Y, Miller G (1999) Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator. J Virol 73(6):4543–4551
Freedman DA, Levine AJ (1998) Nuclear export is required for degradation of endogenous p53 by MDM 2 and human papillomavirus E6. Mol Cell Biol 18(12):7288–7293
Gao Z, Krithivas A, Finan JE, Semmes OJ, Zhou S, Wang Y, Hayward SD (1998) The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J Virol 72(11):8559–8567
Glover J, Harrison S (1995) Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373:257–261
Gutsch DE, Holley-Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC (1994) The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol Cell Biol 14(3):1939–1948
Hammes SR, Greene WC (1993) Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function. Virology 193(1):41–49
Hatton T, Zhou S, Standring DN (1992) RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 66(9):5232–5241
Isfort R, Jones D, Kost R, Witter R, Kung HJ (1992) Retrovirus insertion into herpesvirus in vitro and in vivo. Proc Natl Acad Sci USA 89(3):991–995
Isfort RJ, Qian Z, Jones D, Silva RF, Witter R, Kung HJ (1994a) Integration of multiple chicken retroviruses into multiple chicken herpesviruses: herpesviral gD as a common target of integration. Virology 203(1):125–133
Isfort RJ, Witter R, Kung HJ (1994b) Retrovirus insertion into herpesviruses. Trends Microbiol 2(5):174–177
Jones D, Brunovskis P, Witter R, Kung HJ (1996) Retroviral insertional activation in a herpesvirus:transcriptional activation of US genes by an integrated long terminal repeat in a Marek’s disease virus clone. J Virol 70(4):2460–2467
Jones D, Isfort R, Witter R, Kost R, Kung HJ (1993) Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences. Proc Natl Acad Sci USA 90(9):3855–3859
Jones D, Kung HJ (1992a) A heat-shock-like sequence in the meq gene promoter binds a factor in MDV lymphoblastoid cells. The 19th World’s Poultry Congress. Ponsen and Looijen, Wageningen, Amsterdam, The Netherlands
Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK (1992b) Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors [published erratum appears in Proc Natl Acad Sci USA 1993 Mar 15; 90(6):2556]. Proc Natl Acad Sci USA 89(9):4042–4046
Lai Z, Freedman DA, Levine AJ, McLendon GL (1998) Metal and RNA binding properties of the hdm2 RING finger domain. Biochemistry 37(48):17005–17015
Lazinski D, Grzadzielska E, Das A (1989) Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 59(1):207–218
Lee CZ, Lin JH, Chao M, McKnight K, Lai MM (1993) RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol 67(4):2221–2227
Lee LF, Wu P, Sui D, Ren D, Kamil J, Kung HJ, Witter RL (2000) The complete unique long sequence and the overall genomic organization of the GA strain of Marek’s disease virus. Proc Natl Acad Sci USA 97(11):6091–6096
Lin SF, Robinson DR, Miller G, Kung HJ (1999) Kaposi’s sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol 73(3): 1909–1917
Liu JL, Lee LF, Ye Y, Qian Z, Kung HJ (1997) Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. J Virol 71(4):3188–3196
Liu JL, Lin SF, Xia L, Brunovskis P, Li D, Davidson I, Lee LF, Kung HJ (1999a) MEQ and V-IL8:cellular genes in disguise? Acta Virol 43(2–3):94–101
Liu JL, Ye Y, Qian Z, Qian Y, Templeton DJ, Lee LF, Kung HJ (1999b) Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. J Virol 73(5):4208–4219
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9(6): 1799–1805
Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69(7): 1237–1245
Ohashi K, Morimura T, Takagi M, Lee SI, Cho KO, Takahashi H, Maeka Y, Sugimoto C, Onuma M (1999) Expression of bcl-2 and bcl-x genes in lymphocytes and tumor cell lines derived from MDV-infected chickens. Acta Virol 43(2–3): 128–132
Parcells MS, Dienglewicz RL, Anderson AS, Morgan RW (1999) Recombinant Marek’s disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J Virol 73(2): 1362–1373
Pfitzner E, Becker P, Rolke A, Schule R (1995) Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc Natl Acad Sci USA 92(26): 12265–12269
Qian Z, Brunovskis P, Lee L, Vogt PK, Kung HJ (1996) Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J Virol 70(10):7161–7170
Qian Z, Brunovskis P, Rauscher III F, Lee L, Kung HJ (1995) Transactivation activity of Meq, a Marek’s disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J Virol 69(7):4037–4044
Ross NL (1999) T-cell transformation by Marek’s disease virus. Trends Microbiol 7(1):22–29
Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Embo J 17(2):554–564
Sacher R, Ahlquist P (1989) Effects of deletions in the N-terminal basic arm of brome mosaic virus coat protein on RNA packaging and systemic infection. J Virol 63(11):4545–4552
Sarisky RT, Gao Z, Lieberman PM, Fixman ED, Hayward GS, Hayward SD (1996) A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. J Virol 70(12):8340–8347
Schuermann M, Hunter J, Hennig G, Muller R (1991) Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerization. Nucl Acids Res 19:739–746
Sherr CJ, Weber JD (2000) The ARF/p53 pathway. Curr Opin Genet Dev 10(1):94–99
Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG (1993) EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90(12):5455–5459
Tao W, Levine AJ (1999a) Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2- mediated degradation of p53. Proc Natl Acad Sci USA 96(6):3077–3080
Tao W, Levine AJ (1999b) P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 96(12):6937–6941
Tillotson JK, Lee LF, Kung HJ (1988) Accumulation of viral transcripts coding for a DNA binding protein in Marek’s disease tumor cells. In: Kato S, Horiuchi T, Mikami T, Hirai K (eds) Advance in Marek’s Disease Research Proc. 3rd Intl. Marek’s Disease Symposium. pp 128–134
Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF, Sherr CJ (2000) Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol 20(7):2517–2528
Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1(1):20–26
Xie Q, Anderson AS, Morgan RW (1996) Marek’s disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J Virol 70(2): 1125–1131
Zapp ML, Hope TJ, Parslow TG, Green MR (1991) Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci USA 88(17):7734–7738
Zhang Q, Gutsch D, Kenney S (1994) Functional and physical interaction between p53 and BZLF1:implications for Epstein-Barr virus latency. Mol Cell Biol 14(3): 1929–1938
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kung, HJ., Xia, L., Brunovskis, P., Li, D., Liu, JL., Lee, L.F. (2001). Meq: An MDV-Specific bZIP Transactivator with Transforming Properties. In: Hirai, K. (eds) Marek’s Disease. Current Topics in Microbiology and Immunology, vol 255. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56863-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-56863-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63217-4
Online ISBN: 978-3-642-56863-3
eBook Packages: Springer Book Archive